---
$id: https://graph.org.ai/products/commodity/51172165
$type: Product
source: UNSPSC
code: "51172165"
title: "Darifenacin hydrobromide"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Darifenacin hydrobromide

**UNSPSC Code**: 51172165
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CR02EYQ8GV. European Medicines Agency schedules Darifenacin hydrobromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21464. Darifenacin hydrobromide generally arises in the molecular formula C28H31BRN2O2. The term 'darifenacin hydrobromide' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule darifenacin hydrobromide under HS 29349990 and SITC 51579. As of Q4 2014, DARIFENACIN HYDROBROMIDE remains US FDA's Preferred Term for this commodity. Darifenacin hydrobromide bears US NLM NCI C78068. SMILES: C1CCC(CC1)C(C2CCCCC2)([C@@H]3CCN(C3)CCC4CCC5C(C4)CCO5)C(=O)N.BR.

